Navigation Links
Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
Date:8/19/2007

uted earnings per share were $0.05 in the second quarter of 2006. During the quarter, Skystar recognized non-cash interest expenses related to the debenture interest payment and warrants totaling $622,730. The company did not incur these expenses in the second quarter of 2006.

Adjusting net income to exclude non-cash debt financing and other expenses related to the Company's debenture interest payment and warrants, non-GAAP net income for the second quarter of 2007 was up 59.5% to $771,041 from $483,343 in the second quarter of 2006. Adjusted non-GAAP profit margin was 22.8% compared to 17.5% in the same quarter a year ago. Adjusted non-GAAP fully diluted earnings per share were $0.04 compared to fully diluted earnings per share of $0.05 in the second quarter of 2006.

Six Month Results

Revenues for the first half of 2007 were $4.7 million, up 26% from $3.8 million during the first half of 2006. Gross profit was $2.6 million, or 56% of revenues, up 52% from $1.7 million, or 46% of revenues, in the first half of 2006. Operating income was $1.1 million, or 23% of revenues, up 31% from $829,916, or 22% of sales, in the first half of 2006. Net loss for the first half of 2007 was $222,409, or ($0.26) per diluted share, compared to net income of $637,235, or $0.07 per diluted share, in the same period a year ago. Fully diluted earnings per share for the first six months reflect the one-time non-cash conversion expense of the convertible debentures. Adjusting net income to exclude non-cash debt financing and other expenses related to the Company's convertible debentures and warrants of $755,524, non-GAAP net income was $533,116 million, or $0.03 per fully diluted share, in the first six months of 2007.

Financial Condition

As of June 30, 2007, Skystar Bio-Pharmaceutical had $2.9 million in cash and restricted cash, total liabilities of $2.8 million and working capital of $3.9 million. Shareholders' equity increased to $15.0 million from $9.7 mil
'/>"/>

SOURCE Skystar Bio-Pharmaceutical Co.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Scientific Corporation (NYSE: BSX ) today announced ... aggregate principal amount of its senior notes under the ... of $850 million of 4.50 percent notes due January ... 2020 and $300 million of 7.375 percent notes due ... net proceeds for general corporate purposes, including prepaying its ...
(Date:12/14/2009)... December 14 , - ... of,Women With Rheumatoid Arthritis in Seven Major Industrialized Countries , ... with rheumatoid arthritis say their disease, ... - Women living with rheumatoid arthritis find shopping for ... cards and wrapping presents most, ...
(Date:12/11/2009)... HILL, MA (12/11/2009) Boston College researchers have observed ... the first time and successfully harvested the elusive charges ... improved solar power efficiency, the authors report in the ... , When light is captured in solar cells, it ... But in order to snare these charges, the electrons ...
(Date:12/11/2009)... CALGARY, Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ... today announced the appointment of Dr. Alan Warrander ... Licensing and Business Development. ,, "Dr. Warrander will ... licensing strategy for REOLYSIN(R)," said Dr. Brad Thompson, ... agreement on the design of a Phase 3 ...
Breaking Biology Technology:Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Elusive 'hot' electrons captured in ultra-thin solar cells 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3
... Support Expanded Commercialization of the Revolutionary ... Accuri C6 Flow Cytometer(R) ... Cytometers Inc., a life,sciences company developing revolutionary bench-top flow ... Series C financing led by,Fidelity Biosciences and Flagship Ventures. ...
... GeneGo, Inc., the leading,systems biology tools company, announced ... uses systems analysis tools for,research in its consumer goods ... of GeneGo,s first customers in Europe, and we are,very ... GeneGo,s VP,of Business development. "Unilever is a consumer goods ...
... Blacksburg, Va. From toothpaste to technology, noncrystalline or ... of products that we use in our daily lives. ... an understanding of silica reactivity in physiological environments is ... synthetic materials with bone-like properties. , One ongoing question ...
Other Biology Technology:Accuri Cytometers Completes $13 Million Series C Financing 2Accuri Cytometers Completes $13 Million Series C Financing 3Accuri Cytometers Completes $13 Million Series C Financing 4Unilever Extends Their GeneGo MetaCore License 2New insight to demineralization 2
(Date:12/11/2009)... the 4th edition of Springer,s classic reference and textbook ... Victor A. McKusick Leadership Award. The prize, which recognizes ... genetics, was presented to him at the 59th Annual ... 24 October 2009 in Honolulu, Hawaii. , Motulsky is ... University of Washington in Seattle. One of the founding ...
(Date:12/11/2009)... CORVALIS, ORFruit growers, profits have traditionally been ... climates where growing seasons can be short. ... developed varieties are being introduced that offer ... the offseasonresulting in economic bonuses for both ... new varieties of blackberry called "primocane-fruiting", which ...
(Date:12/11/2009)... health risk but why do teens become addicted to ... Faculty of 1000 Biology, Neil Grunberg looks into why ... describes the study, published by Natividad et al. in ... "may have implications to help understand why adolescents are ... level of dopamine in the brain, a neurotransmitter that ...
Breaking Biology News(10 mins):New management methods extend blackberry season 2Clemson researchers say algae key to mass extinctionss 10451 1Clemson researchers say algae key to mass extinctionss 10451 2Smallest nanoantennas for high speed data networks 14552 1Smallest nanoantennas for high speed data networks 14552 2Smallest nanoantennas for high speed data networks 14552 3In Case You Missed It 3A Landrieu Discusses Health Care Reform on MSNBC 59868 1
... farming produces the same yields of corn and soybeans ... energy, less water and no pesticides, a review of ... a Cornell University professor of ecology and agriculture, concludes, ... corn and soybeans." Pimentel is the lead author of ...
... to explain human social behavior and disorders such as autism ... researchers funded, in part, by the National Institutes of Health's ... for Research Resources (NCRR). , The researchers traced social behavior ... determines when and where a gene turns on. The length ...
... may be one of the first medical uses of nanotechnology, ... diseases have joined forces to create an early detection method ... of hospitalization among children under five. , Respiratory syncytial virus ... United States each year. Although it is only life-threatening in ...
Other Biology News:Organic farms produce same yields as conventional farms 2Rodent social behavior encoded in junk DNA 2Rodent social behavior encoded in junk DNA 3Quantum dots provide a faster, more sensitive method for detecting respiratory viral infections 2Quantum dots provide a faster, more sensitive method for detecting respiratory viral infections 3Quantum dots provide a faster, more sensitive method for detecting respiratory viral infections 4
... ISO 9001:2000 Certified USDA Research Registered ... SOP's Training AALAS Certified Technicians ... Procedures GLP Documentation Upon Request Focus ... point for all your custom immunology service ...
Applications: Western blotting ...
... by collecting data from any RS232 based ... is extremely easy to use and will ... An excellent solution for collecting data ... gauges, digital calipers, bar code readers, etc. ...
One unit is equal to 10Kb (insert DNA + vector). The final cost will increase or decrease according to the final assembled genome size. The price does not include genome annotation....
Biology Products: